As Vice President, Business Development for Johnson & Johnson MedTech – a $27 billion business unit of Johnson & Johnson – Jennifer Kozak directs corporate initiatives including strategic, investment and portfolio decisions.
During her tenure at Johnson & Johnson, Jennifer has held numerous positions leading business development activities with increasing responsibility for strategic planning and portfolio optimization. Today, Jennifer is a member of Johnson & Johnson’s MedTech Leadership Team and oversees all business development activity to drive growth, innovation, competitiveness, and value for Johnson & Johnson.
Jennifer has executed more than $7 billion in transactions during her tenure at Johnson & Johnson. Most recently, she led the acquisitions of Auris Health and Verb Surgical, expanding J&J’s digital surgery portfolio and capabilities. Prior to her role in Digital Surgery, Jennifer led business development activities for New Growth Platforms, where she was instrumental in enhancing and implementing a more robust strategic planning and business unit portfolio optimization process. She also developed new external innovation models partnering with Johnson & Johnson Development Corporation (JJDC) to optimize J&J’s equity investment strategy and portfolio. Additionally, Jennifer led a broad-based assessment of the Medical Device landscape to identify new business opportunities, drove strategy to enter the ENT (Ears, Nose, Throat) space and led the acquisition of Acclarent. She also executed numerous other new business development transactions and projects, including the acquisition of Angiotech’s knotless tissue closure device and led a global cross-functional team charged with accelerating the performance of J&J’s acquisitions.
Jennifer began her career at Johnson & Johnson as an engineer at Johnson & Johnson Interventional Systems prior to the merger with Cordis Corporation. While at Cordis, she held various roles in Operations, R&D and New Business Development.
Jennifer earned a B.S. in Chemical Engineering from Bucknell University and completed the Smith College Leadership Consortium Executive Education.
